# Vice President, Research — Iovance Biotherapeutics

- Location: Tampa, FL
- Posted: Nov 18, 2026
- Status: open (checked Nov 21, 2026)
- Apply (employer's site): https://job-boards.greenhouse.io/iovancebiotherapeutics/jobs/5477234008
- Employer record: https://visajobs.io/company/iovance-biotherapeutics.md

## Sponsorship history
- Tier: Employer history only
- With this exact title: 0

## Description
About   Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics , Inc.  is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The  Iovance TIL platform  spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit  www.iovance.com .
Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners.
Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on  www.iovance.com .
Overview
The Vice President, Research will provide strategic and operational leadership across translational sciences, platform research, bioinformatics, and preclinical research activities supporting Iovance’s industry-leading tumor infiltrating lymphocyte (TIL) therapy platform and next-generation cellular immunotherapy pipeline.
As the leader in commercializing the first FDA-approved TIL therapy, Amtagvi®, Iovance is pioneering innovative approaches to harness the immune system to treat solid tumors. Reporting to the Executive Vice President, Translational Medicine & Research, the VP, Research will play a critical role in advancing discovery and translational research programs, driving IND-enabling activities, and expanding the scientific foundation of Iovance’s cellular therapy platforms.
The ideal candidate is an accomplished biotechnology leader with deep expertise in cell therapy, tumor immunology, translational medicine, and preclinical drug development. This individual will oversee multidisciplinary scientific teams spanning translational sciences, bioinformatics, platform research, and preclinical development, while partnering cross-functionally to accelerate innovative therapies into the clinic.
Essential Functions and Responsibilities
Scientific & Strategic Leadership
Lead and oversee translational sciences, platform research, bioinformatics, and preclinical research functions supporting Iovance’s TIL therapy and immuno-oncology pipeline.
Partner closely with the EVP, Translational Medicine & Research to define and execute research strategy aligned with corporate and pipeline objectives.
Advance next-generation cellular therapy approaches through innovation in tumor immunology, immune cell engineering, and translational biology.
Drive scientific rigor, innovation, and operational excellence across research and translational programs.
Translational Sciences & IND-Enabling Research
Lead translational medicine strategies supporting biomarker discovery, patient selection, mechanism-of-action studies, and translational endpoints.
Oversee IND-enabling research activities, including preclinical pharmacology, proof-of-concept studies, and translational data packages supporting regulatory submissions.
Ensure effective integration of translational findings into clinical development strategies and decision-making.
Collaborate with Regulatory, Clinical Development, and CMC teams to support successful advancement of programs into clinical trials.
Platform & Preclinical Research Leadership
Provide scientific leadership for platform research initiatives focused on advancing and differentiating Iovance’s cellular therapy technologies.
Oversee preclinical research activities supporting pipeline expansion and next-generation platform innovation.
Guide evaluation and implementation of emerging technologies relevant to cell therapy, protein sciences, bioinformatics, and viral/vector-related approaches.
Bioinformatics & Computational Biology
Lead bioinformatics and computational biology capabilities supporting genomic, transcriptomic, proteomic, and multi-omic analyses.
Ensure computational and translational insights are integrated into research strategy, target identification, biomarker development, and clinical translation.
Cross-Functional Collaboration
Collaborate closely with Clinical Development, Technical Operations, Manufacturing, Regulatory Affairs, and CMC teams to advance programs from discovery through early clinical development.
Contribute scientific leadership to portfolio prioritization, governance discussions, and external partnership evaluations.
Support diligence activities and scientific assessments for external collaborations and platform opportunities.
Team Leadership & Organizational Development
Build, mentor, and lead high-performing multidisciplinary scientific teams.
Foster a culture of innovation, accountability, collaboration, and scientific excellence.
Recruit and retain top scientific talent within a fast-paced and evolving biotechnology environment.
External Scientific Engagement
Represent Iovance within the scientific and medical community through publications, conferences, scientific advisory interactions, and external collaborations.
Maintain awareness of scientific and competitive developments across cell therapy, immuno-oncology, and translational medicine landscapes.
Required Education, Skills, and Knowledge
Education
PhD, MD, or MD/PhD in Immunology, Oncology, Molecular Biology, Cell Biology, Bioengineering, or related scientific discipline required.
Experience
15+ ye

> History, not a promise: past H-1B filings do not mean an employer will sponsor you or a given role. Data: U.S. DOL OFLC LCA disclosure (FY2024–FY2026 for role counts, certified LCAs) and the USCIS H-1B Employer Data Hub. Not legal advice. Methodology: https://visajobs.io/methodology
